Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia

A preliminary investigation into the effects of antipsychotics on sub-chronic phencyclidine-induced deficits in attentional set-shifting in female rats

(2008) Samantha L. McLean et al.   BEHAVIOURAL BRAIN RESEARCH

Activation of Cannabinoid-1 Receptors Disrupts Sensory Gating and Neuronal Oscillation: Relevance to Schizophrenia

(2008) Mihály Hajós et al.   BIOLOGICAL PSYCHIATRY

Modelling prefrontal cortex deficits in schizophrenia: implications for treatment

(2008) J A Pratt et al.   BRITISH JOURNAL OF PHARMACOLOGY

Why endocannabinoids are not all alike

(2008) Vincenzo Di Marzo et al.   NATURE NEUROSCIENCE

Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum

(2008) Mauro Maccarrone et al.   NATURE NEUROSCIENCE

Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis

(2008) Daniel Marcellino et al.   NEUROPHARMACOLOGY

Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats

(2008) Alice Egerton et al.   PSYCHOPHARMACOLOGY

Functional neuroimaging in schizophrenia: diagnosis and drug discovery

(2008) P MCGUIRE et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antibiotic drug minocycline

(2007) Yuko Fujita et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Loss of Cannabinoid-Stimulated Guanosine 5′-O-(3-[35S]Thiotriphosphate) Binding Without Receptor Down-Regulation in Brain Regions of Anandamide-Tolerant Rats

(2003) T. Rubino et al.   JOURNAL OF NEUROCHEMISTRY